Pandemic-scale Pathogen Detection

Avicena is an award-winning Australian medical technology company that has developed the ground-breaking Sentinel Biosecurity Platform. The Sentinel is an accurate, rapid, and scalable molecular diagnostic instrument capable of detecting diverse pathogens, including COVID-19.

The Sentinel instrument can process more than 90,000 samples daily with data available in under 40 minutes.

Learn more

A revolutionary molecular assay instrument designed to deliver

92,160

Samples per day per instrument

3,840

Samples per hour per instrument

35 min

Average turnaround time

Latest News

In the Media – Avicena gains TGA Authorisation, WA Business News
In the Media – Avicena gains TGA Authorisation, WA Business News

September 7, 2022

Avicena unveils second generation Sentinel
Avicena unveils second generation Sentinel

October 18, 2021

Avicena wins top prize at national iAwards 2021
Avicena wins top prize at national iAwards 2021

September 9, 2021

See more news
Intended Use

The Avicena Sentinel instrument is intended for trained laboratory professionals to run isothermal amplification assays. Diagnostic use of the Sentinel requires IVD reagents and laboratory workflows which have been authorised by relevant regulatory agencies in each jurisdiction and by Avicena Systems as compatible with the instrument.